Satellos Bioscience (STU:0IT) Tariff Resilience Score: 7/10 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:0IT Satellos Bioscience Inc STU:0IT
36 GF Score
Price €8.00
! 1 Warning Sign
View Full Analysis

What is Satellos Bioscience Tariff Resilience Score?

Satellos Bioscience STU:0IT -1.84% 36 Tariff Resilience Score is 7 as of Jul. 14, 2026. GuruFocus rates STU:0IT with a GF Score™ of 36/100. The stock has 1 warning sign investors should review. Among 1,370 Biotechnology companies, Satellos Bioscience ranks better than 90.36% on this metric.

Satellos Bioscience has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Satellos Bioscience has Satellos Bioscience operates in the biotech sector, with limited direct exposure to tariffs. While global supply chains are involved, the impact of tariffs is less significant compared to other industries.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Satellos Bioscience might have Highly Resilient.

Satellos Bioscience  (STU:0IT) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Satellos Bioscience Tariff Resilience Score Related Terms

STU:0IT vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Satellos Bioscience's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Satellos Bioscience Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's Tariff Resilience Score falls into.


STU:0IT
36GF Score
Satellos Bioscience Inc STU:0IT
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Satellos Bioscience (STU:0IT) has a Tariff Resilience Score of 7 as of Jul. 14, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Satellos Bioscience ranks #132 out of 1370 companies in the Biotechnology industry, placing it in the top 9.6%.
Is Satellos Bioscience's Tariff Resilience Score too high?
Satellos Bioscience's current Tariff Resilience Score is 7. The Biotechnology industry median Tariff Resilience Score is 4.00. Satellos Bioscience's value of 7 is 75% above this industry median. Based on the distribution chart, Satellos Bioscience ranks #132 out of 1370 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Satellos Bioscience has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Satellos Bioscience's Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Satellos Bioscience ranks #132 out of 1370 companies for Tariff Resilience Score. This places Satellos Bioscience in the top 10% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Satellos Bioscience's value of 7 is 75% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,370 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Satellos Bioscience's current Tariff Resilience Score of 7 is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Satellos Bioscience's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Satellos Bioscience stock overvalued right now?
Satellos Bioscience (STU:0IT) has a current Tariff Resilience Score of 7. The current Tariff Resilience Score is 7 and 75% above the Biotechnology industry median of 4.00. Satellos Bioscience's overall GF Score™ is 36/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Satellos Bioscience (STU:0IT), the current Tariff Resilience Score is 7 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Satellos Bioscience Business Description

Address 200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
36GF Score

Get the complete analysis for STU:0IT

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.00
Price